GlycoNet is advancing research, innovation, and training in glycomics to improve the quality of life of Canadians.

GlycoNet is a one-stop global destination focused on developing new carbohydrate-based drugs, vaccines and diagnostics, in collaboration with academic and industry organizations to address areas of unmet need through applied glycomics research. This national platform supports translational research, protection of intellectual property, novel drug development, company formation and training of a new generation of glyco-scientists and entrepreneurs. The network includes over 170 researchers across Canada who focus on cancer, chronic diseases, infectious diseases, and neurodegenerative diseases.

GlycoNet is funded by the Government of Canada through the Networks of Centres of Excellence (NCE) Program.

Network Investigators
Trained HQP
Funded Projects
Network Partners

Latest News

GlycoNet Scientific Director and PlantForm awarded grant to enable commercial-scale production of protein drugs

The NSERC Alliance Grant will support the advancement of glycoengineering technology for plant-derived proteins.

Dr. Warren Wakarchuk appointed Scientific Director of GlycoNet

The new Scientific Director will be responsible for leading GlycoNet’s scientific strategy and the Network’s global leadership in glycoscience.

Using plants to find new treatments for type 2 diabetes

GlycoNet researchers found more efficient ways to produce montbretin A, a potential anti-diabetes compound.

Quick Links

Upcoming Events

There are no upcoming events.

Network Members


Scroll to Top